Kalpataru IPO Allotment Today: A Step-By-Step Guide To Check Status Online, Know Latest GMP
Last Updated:
The GMP of the Kalpataru IPO currently stands at 0.72%, indicating flat or negative listing.
Kalpataru IPO Allotment Status, GMP: The initial public offering (IPO) of real estate developer Kalpataru Ltd has been closed, and the investors are now awaiting its allotment, which is expected to be finalised today, Friday, June 27. Investors will start receiving bank debit messages once the application is approved. They can also check the allotment status on the websites of the BSE, the National Stock Exchange (NSE), and registrar Link Intime.
The Kalpataru IPO allotment will take place on today, June 27, most probably in the evening. The IPO allotment status can be checked online by following these steps:
1) Go to the official BSE website via the URL — https://www.bseindia.com/investors/appli_check.aspx.
2) Under 'Issue Type', select 'Equity'.
3) Under 'Issue Name', select 'Kalpataru Ltd' in the dropbox.
4) Enter your application number, or the Permanent Account Number (PAN).
5) Then, click on the 'I am not a robot' to verify yourself and hit the 'Search' option.
Your share application status will appear on your screen.
You can also visit directly on the registrar Link Intime's portal — https://in.mpms.mufg.com/Initial_Offer/public-issues.html and check the Kalpataru IPO allotment status.
According to market observers, the GMP of the IPO currently stands at 0.72%, indicating flat or negative listing.
The GMP is based on market sentiments and keeps changing. 'Grey market premium' indicates investors' readiness to pay more than the issue price.
Kalpataru IPO Allotment Date & Listing Date
The allotment is expected to be finalised today, Friday, June 27. Its listing is scheduled to take place on June 1 on both BSE and NSE.
Kalpataru IPO: More Info
The Kalpataru IPO was open between June 24 and June 26. It is entirely a fresh issue of equity shares worth Rs 1,590 crore with no offer for sale (OFS) component. It proposes to utilise funds for the payment of debt and general corporate purposes.
On the final day of bidding on Thursday, the Rs 1,590-crore IPO received a 2.31 times subscription, garnering bids for 4,93,44,660 shares as against the 2,13,34,828 shares on offer. The retail and NII participation stood at 1.43 times and 1.40 times, respectively. Its qualified institutional buyer (QIB) category got a 3.12 times subscription.
The price band of the IPO was fxed in the range of Rs 387 to Rs 414 per share.
Kalpataru Ltd raised Rs 708 crore from anchor investors a day ahead of the launch of its IPO for public subscription.
About Kalpataru Ltd
Mumbai-based Kalpataru focuses on the development of residential, commercial, retail and integrated township projects. It is also in the redevelopment of societies.
Kalpataru is one of the leading real estate developers in the country with a significant presence in the Mumbai Metropolitan Region (MMR) in Maharashtra.
As per the latest red herring prospectus, the company sold properties worth Rs 2,727.24 crore during April-December of the last fiscal on strong demand for housing and commercial assets.
The company sold properties worth Rs 3,201.98 crore in FY 2023-24.
tags :
initial public offering (IPO) IPO
Location :
New Delhi, India, India
First Published:
June 27, 2025, 10:47 IST
News business » ipo Kalpataru IPO Allotment Today: A Step-By-Step Guide To Check Status Online, Know Latest GMP
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
22 minutes ago
- Indian Express
BMC extends deadline for waste bioremediation at Deonar for a third time
For the third time, the Brihanmumbai Municipal Corporation (BMC) has extended its deadline for the Rs 2,368 crore tender to appoint a contractor to carry out bioremediation of 185 lakh tonnes of waste and reclaim 110 hectare of land at the Deonar dumpsite over a period of three years. Bioremediation is a process involving treating garbage with the help of natural elements like air, sunlight, and microorganisms. Over time, as the biodegradable waste decomposes, the remaining non-biodegradable extracts are either recycled or treated artificially. The process of bioremediation is proposed at the Deonar dumpsite, which is among one of the sites that have been selected by the state government for constructing housing tenements for the Dharavi Redevelopment Project (DRP) – a venture steered by the Adani group and Maharashtra government's Slum Rehabilitation Authority (SRA). Earlier on May 14, the civic body had floated a tender inviting bidders to clear the Deonar dumpsite through bioremediation with a deadline of June 3, which was later extended to June 23 and further, revised to July 1. On Saturday, for the third time in a month, the BMC has again extended the deadline for the bidders to July 4. In the revised corrigendum, the civic body has revised the conditions, permitting a price escalation of five percent after 2 years. According to officials, the deadline has been revised owing to extension requested by bidders amid several concerns. For the record, at least 23 bidders had come forward and expressed interest during a pre-bid meeting convened earlier. 'Primarily, there are two major concerns which have been raised by the bidders. Firstly, the concerns pertain to the price as there was no provision for price escalation in the initial tender clause. Furthermore, many interested bidders had requested allocation of more time to collect and submit the documents. Another reason is the unique nature of the work stipulated in the tender, wherein nearly 2 crore metric tonnes of legacy waste has to be cleared over a period of three years,' said a civic official. 'This is our final corrigendum, following which no other extensions will be granted.' According to the civic data, of the 1.85 crore metric tonnes of waste which is currently stacked at the dumpsite, nearly 48 percent comprises construction debris, 41 percent is inert waste while 10 percent is accounted for by dry, miscellaneous waste.
India.com
30 minutes ago
- India.com
Tata Steel Gets GST Show-Cause Notice Over Alleged Rs 1,000 Crore Tax Credit Irregularity
Mumbai: Tata Steel on Sunday said it has received a show-cause-cum-demand notice from the tax department over an alleged irregular use of input tax credit worth over Rs 1,000 crore for the financial years 2018-19 to 2022-23. In a filing to the stock exchanges, the company said that the notice was issued by the Office of the Commissioner (Audit), Central Tax, Ranchi, on June 28. "On June 28, Tata Steel Limited received a Show Cause cum demand Notice dated June 27, issued by the Office of the Commissioner (Audit), Central Tax, Ranchi, proposing to disallow/demand primarily on account of alleged irregular availment of Input Tax Credit in contravention of the provisions of Section 74(1) of the Central Goods and Services Tax Act, 2017/State Goods and Services Act, 2017 read with Section 20 of the Integrated Goods and Services Tax Act, 2017, for the period FY2018-19 through FY2022-23," the firm said in its filing. The tax authority asked Tata Steel to explain, within 30 days, why the GST amounting to Rs 1,007.54 crore should not be demanded and recovered from the company. The explanation has to be submitted before the Additional or Joint Commissioner of Central GST & Central Excise in Jharkhand's Jamshedpur. According to the notice, Tata Steel allegedly claimed input tax credit in violation of the GST rules -- specifically Section 74(1) of the Central Goods and Services Tax Act, 2017, and Section 20 of the Integrated Goods and Services Tax Act, 2017. Tata Steel clarified that it has already paid Rs 514.19 crore as GST in the normal course of business. This amount is proposed to be adjusted in the notice, reducing the company's actual tax exposure to about Rs 493.35 crore. The company has said it believes the notice is without merit and will present its case before the authorities within the given deadline. Tata Steel also stated that this matter does not affect its financial, operational, or other business activities. Under the GST system, businesses can claim input tax credit on the taxes paid for purchases used in the production of goods or services. This credit helps in reducing their overall tax liability.
Mint
35 minutes ago
- Mint
Torrent Pharma to acquire majority stake in KKR-backed JB Chemicals at ₹25,689 crore valuation — Details here
Gujarat-based pharmaceutical giant Torrent Pharma announced on Sunday, 29 June 2025, that it is in definitive agreements with global investment giant KKR to acquire a majority stake in JB Chemicals, according to an exchange filing. The potential acquisition details show that the company plans to acquire J. B. Chemicals and Pharmaceuticals (JB Pharma) at an equity valuation of ₹ 25,689 crore on a fully diluted basis, which will be followed by a merger of the two companies. JB Pharma's promoter company, Tau Investment Holdings, is a KKR-owned investment vehicle which the global giant uses to own a stake in the pharma major. Tau Investment is a legally distinct legal entity of KKR & Co. Inc. Tau Investment currently holds a 47.84% stake in J. B. Chemicals and Pharmaceuticals, according to BSE data as on Sunday, 29 June 2025. The deal is set to be carried out in several phases. In the first phase, Torrent Pharma will acquire a 46.39% stake through a share purchase agreement (SPA), which will total ₹ 11,917 crore at the rate of ₹ 1,600 per share. After the first phase, the company will introduce a mandatory open offer to acquire up to 26% of JB Pharma shares from public stakeholders at an open offer price of ₹ 1,639.18 per share. The acquiring company also plans to acquire another 2.80% stake in the company from certain employees holding a stake of JB Pharma at the same price per share as KKR selling its stake. The company also announced its plans for a merger between Torrent and JB Pharma through a scheme of arrangement where every shareholder holding 100 shares in JB Pharma will receive 51 shares of Torrent Pharmaceuticals. 'We are pleased to have on board the JB Pharma heritage and build on the platform for the future. Torrent's deep India presence and JB Pharma's fast-growing India business, combined with the CDMO and international footprint offers immense potential to scale both revenue and profitability,' said Samir Mehta, the Executive Chairman of Torrent Pharma in the official statement. JB Chemicals & Pharmaceuticals shares closed 2.72% higher at ₹ 1,799.35 after Friday's stock market session, compared to ₹ 1,751.75 in the previous market close. Shares of the pharma company have given more than 398% returns on investment in the last five years. However, the stock has lost 0.03% in the last one-year period. On a year-to-date (YTD) basis, the shares are down 4.58% in 2025, but are currently trading 6.02% higher in the last one-month period. Torrent Pharmaceuticals shares also closed with 3.68% gains on Friday's market at ₹ 3,344.40, compared to ₹ 3,225.70 in the previous stock market session last week. Pharma major Torrent Pharmaceuticals shares have gained 181% in the last five years and are trading 21.35% higher in the last one-year period. The shares are trading 6.94% higher in the last five trading sessions. Read all stories by Anubhav Mukherjee Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.
